N-(4-(HYDROXYMETHYL)-3-(TRIFLUOROMETHYL)PHENYL)-3-(2-IMIDAZO(1,2-B)PYRIDAZIN-3-YLETHYNYL)-4-METHYLBENZAMIDE
UNII JC36235WGQ
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(4-(hydroxymethyl)-3-(trifluoromethyl)phenyl)-3-(2-imidazo(1,2-b)pyridazin-3-ylethynyl)-4-methylbenzamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JC36235WGQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1638194-04-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H17F3N4O2 XHABLRZVDSDYMQ-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(4-(hydroxymethyl)-3-(trifluoromethyl)phenyl)-3-(2-imidazo(1,2-b)pyridazin-3-ylethynyl)-4-methylbenzamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.